Abstract
In a number of mammalian cell types, pteridine biosynthesis from guanosine 5'-triphosphate and formation of nitric oxide from L-arginine are induced by gamma interferon (IFN-gamma) and bacterial lipopolysaccharide (LPS). We assessed the possibility of using such metabolic alterations for the in vitro detection of pyrogens. Products from gram-negative and gram-positive bacteria and related synthetic compounds were tested for their potential to induce either of these pathways. Stimulation of pteridine biosynthesis was monitored as the formation of neopterin in the human myelomonocytic cell line THP-1. The formation of nitric oxide was determined as nitrite in murine J774A.1 macrophage cultures. The substances tested included toxic and detoxified parts of LPS and lipid A from Escherichia coli, Salmonella typhimurium, Salmonella minnesota, and Klebsiella pneumoniae as well as lipoteichoic acid and toxic shock syndrome toxin 1 from Staphylococcus aureus. Furthermore, two cell wall compounds from Mycobacterium tuberculosis, trehalose 6,6'-dimycolate and N-acetylmuramyl-L-alanyl-D-isoglutamine, which are active components of Freund's adjuvant, were used. When applied as a single stimulus, only the whole LPS molecule potently stimulated neopterin or nitrite formation. Lipid A and products from gram-positive bacteria were weakly active. For neopterin formation, lipid A required the presence of fetal calf serum. Besides detoxified LPS and independently from the presence of serum, all bacterial compounds tested strongly increased the effects mediated by IFN-gamma. Our results show that bacterial pyrogens can be detected by monitoring the formation of neopterin or nitrite. This may provide a basis for the development of an in vitro assay for the detection of pyrogenic contamination with the aim of replacing the currently used animal test.
Full Text
The Full Text of this article is available as a PDF (227.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Essery S. D., Saadi A. T., Twite S. J., Weir D. M., Blackwell C. C., Busuttil A. Lewis antigen expression on human monocytes and binding of pyrogenic toxins. Agents Actions. 1994 Mar;41(1-2):108–110. doi: 10.1007/BF01986408. [DOI] [PubMed] [Google Scholar]
- Glauser M. P., Heumann D., Baumgartner J. D., Cohen J. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin Infect Dis. 1994 Feb;18 (Suppl 2):S205–S216. doi: 10.1093/clinids/18.supplement_2.s205. [DOI] [PubMed] [Google Scholar]
- Lynn W. A., Golenbock D. T. Lipopolysaccharide antagonists. Immunol Today. 1992 Jul;13(7):271–276. doi: 10.1016/0167-5699(92)90009-V. [DOI] [PubMed] [Google Scholar]
- Martin E., Nathan C., Xie Q. W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med. 1994 Sep 1;180(3):977–984. doi: 10.1084/jem.180.3.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mayersbach P., Augustin R., Schennach H., Schönitzer D., Werner E. R., Wachter H., Reibnegger G. Commercial enzyme-linked immunosorbent assay for neopterin detection in blood donations compared with RIA and HPLC. Clin Chem. 1994 Feb;40(2):265–266. [PubMed] [Google Scholar]
- Misfeldt M. L. Microbial "superantigens". Infect Immun. 1990 Aug;58(8):2409–2413. doi: 10.1128/iai.58.8.2409-2413.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
- Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
- Palacios M., Knowles R. G., Moncada S. Enhancers of nonspecific immunity induce nitric oxide synthase: induction does not correlate with toxicity or adjuvancy. Eur J Immunol. 1992 Sep;22(9):2303–2307. doi: 10.1002/eji.1830220919. [DOI] [PubMed] [Google Scholar]
- Raetz C. R., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991 Sep;5(12):2652–2660. doi: 10.1096/fasebj.5.12.1916089. [DOI] [PubMed] [Google Scholar]
- Retzinger G. S., Meredith S. C., Takayama K., Hunter R. L., Kézdy F. J. The role of surface in the biological activities of trehalose 6,6'-dimycolate. Surface properties and development of a model system. J Biol Chem. 1981 Aug 10;256(15):8208–8216. [PubMed] [Google Scholar]
- Werner-Felmayer G., Werner E. R., Fuchs D., Hausen A., Reibnegger G., Wachter H. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res. 1990 May 15;50(10):2863–2867. [PubMed] [Google Scholar]
- Werner-Felmayer G., Werner E. R., Fuchs D., Hausen A., Reibnegger G., Wachter H. Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler. 1989 Sep;370(9):1063–1069. doi: 10.1515/bchm3.1989.370.2.1063. [DOI] [PubMed] [Google Scholar]
- Werner E. R., Werner-Felmayer G., Fuchs D., Hausen A., Reibnegger G., Yim J. J., Wachter H. Impact of tumour necrosis factor-alpha and interferon-gamma on tetrahydrobiopterin synthesis in murine fibroblasts and macrophages. Biochem J. 1991 Dec 15;280(Pt 3):709–714. doi: 10.1042/bj2800709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werner E. R., Werner-Felmayer G., Wachter H. Tetrahydrobiopterin and cytokines. Proc Soc Exp Biol Med. 1993 May;203(1):1–12. doi: 10.3181/00379727-203-43566a. [DOI] [PubMed] [Google Scholar]
- Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994 Feb 18;269(7):4705–4708. [PubMed] [Google Scholar]